Market Place
Sourcing Support
Sanofi India, NHM MP Partner to Boost NCD, Rare Disease Access
08 May 2026 //
INDPHARMAPOST
Sanofi Asks to Pull Tzield Bid from FDA`s Controversial CNPV
06 May 2026 //
REUTERS
Sanofi Invests $294M in Toronto AI Excellence Center
06 May 2026 //
BIOSPACE
Sanofi India Names Rahul Bhatnagar Chairman Of Board
03 May 2026 //
INDPHARMAPOST
Sanofi Names Belén Garijo CEO and Director on April 29, 2026
29 Apr 2026 //
GLOBENEWSWIRE
Sanofi Consumer Healthcare Reports 33% Revenue Growth In Q1
29 Apr 2026 //
INDPHARMAPOST
Regeneron Reports Q1 2026 Financial and Operating Results
29 Apr 2026 //
GLOBENEWSWIRE
Lilly Inks Deals; Regeneron Secures Historic Q1 Win
29 Apr 2026 //
BIOSPACE
Sanofi CEO Garijo Aims To Reduce Dependence On Dupixent
28 Apr 2026 //
BIOSPACE
Sanofi`s Cenrifki For Secondary Progressive Ms Recommended
24 Apr 2026 //
GLOBENEWSWIRE
Sanofi Prices $2.3B Bond Issue
24 Apr 2026 //
GLOBENEWSWIRE
Gujarat Themis Biosyn Acquires Anti-Tb Brands From Sanofi
24 Apr 2026 //
INDPHARMAPOST
Sanofi has `vigorous defense planned` for Dupixent patent cliff
24 Apr 2026 //
FIERCE PHARMA
Sanofi Defends Dupixent Patents Amid CEO Change
23 Apr 2026 //
BIOSPACE
Sanofi Has `Vigorous Defense Planned` For Dupixent Patent Cliff
23 Apr 2026 //
FIERCE PHARMA
Sanofi CFO Defends Hudson`s Legacy, Accepts R&D `Setbacks`
23 Apr 2026 //
FIERCE BIOTECH
Sanofi `Fully Committed` to Garijo Appointment
23 Apr 2026 //
ENDPOINTS
Sanofi`s Tzield FDA Approved To Delay Stage 3 Type 1 Diabetes
22 Apr 2026 //
PRESS RELEASE
Sanofi CEO Confronts Immunology R&D Strategy Challenge
22 Apr 2026 //
ENDPOINTS NEWS
Dupixent Approval For Children With Chronic Spontaneous Urticaria
22 Apr 2026 //
PRESS RELEASE
Sanofi`s new COVID shot tops Moderna`s mNexspike in safety trial
20 Apr 2026 //
PRESS RELEASE
Sanofi, DKSH Partner to Boost Treatment Access in Malaysia
16 Apr 2026 //
PRESS RELEASE
Sanofi: Total Voting Rights and Shares as of Mar 2026
14 Apr 2026 //
GLOBENEWSWIRE
Dupixent Receives EU Approval For Young Children With CSU
13 Apr 2026 //
PRESS RELEASE
Sanofi to Hold Combined General Meeting on April 29
08 Apr 2026 //
GLOBENEWSWIRE
Sanofi’s lunsekimig met primary and key secondary endpoints
07 Apr 2026 //
PRESS RELEASE
Anthropic Puts $400M Into Coefficient Bio Life Sciences
06 Apr 2026 //
BIOSPACE
ACOFP Gathers Experts at Chronic Disease Summit
06 Apr 2026 //
PHARMIWEB
Novavax Boosts `Amplification Strategy` Through Sanofi, Pfizer
06 Apr 2026 //
FIERCE PHARMA
EU Approves Sanofi`s Rezurock for Chronic GVHD Disease
31 Mar 2026 //
PRESS RELEASE
Sanofi, Incyte, Roivant, Alumis Advance In Skin Disease Research
31 Mar 2026 //
BIOSPACE
Sanofi Shares Phase 3 Amlitelimab Data for AD at AAD Meeting
28 Mar 2026 //
PRESS RELEASE
Q1 2026 Aide-Mémoire Now Available
24 Mar 2026 //
PRESS RELEASE
Dupixent Approved in Japan for Bullous Pemphigoid (BP)
24 Mar 2026 //
PRESS RELEASE
Kali signs deal with Sanofi to develop autoimmune Treatment
23 Mar 2026 //
REUTERS
Earendil Labs Secures $787M To Expand AI-Driven Biologics R&D
20 Mar 2026 //
PR NEWSWIRE
Sanofi launches innovation and operation centre in China
20 Mar 2026 //
REUTERS
Mirecule Expands Strategic FSHD Collaboration With Sanofi
18 Mar 2026 //
PHARMIWEB
Sanofi’s Venglustat Earns BTD in US for Type 3 Gaucher Disease
18 Mar 2026 //
GLOBENEWSWIRE
Sanofi Reports Total Voting Rights And Shares For February 2026
12 Mar 2026 //
GLOBENEWSWIRE
Sanofi Sells Generics Unit To Brazil`s EMS
06 Mar 2026 //
PRESS RELEASE
Sanofi Board Proposes Christel Heydemann As Independent Director
06 Mar 2026 //
PRESS RELEASE
Teva`s $400M Blackstone deal to fund Sanofi-partnered IBD drugTev
05 Mar 2026 //
GLOBENEWSWIRE
Sanofi inks $1.5B Deal For Sino Biopharm`s Novel Asset
05 Mar 2026 //
FIERCE PHARMA
Sanofi`s Rilzabrutinib Granted Orphan Drug Status In Japan
03 Mar 2026 //
PRESS RELEASE
Blueprint Reports 4-Year Data in Indolent Systemic Mastocytosis
28 Feb 2026 //
PR NEWSWIRE
EU CHMP Recommends Dupixent for Pediatric Chronic Urticaria
27 Feb 2026 //
PRESS RELEASE
DNDi, Sanofi Get CHMP Nod for Single-Dose Sleeping Sickness Tx
27 Feb 2026 //
PRESS RELEASE
Dupixent picks up 9th FDA approval
25 Feb 2026 //
PRESS RELEASE
Pharma Firm Files 2025 US 20-F and French Annual Report
17 Feb 2026 //
PRESS RELEASE
Sanofi points to long-term efficacy of Teva-partnered IBD drug
17 Feb 2026 //
PRESS RELEASE
Drugmaker Sanofi To Expand India GCC, Increase Workforce
17 Feb 2026 //
ECONOMICTIMES
Beyfortus study published in The Lancet Infectious Diseases
16 Feb 2026 //
PRESS RELEASE
Merck KGaA`s Belen Garijo To Become CEO Of Sanofi
13 Feb 2026 //
INDPHARMAPOST
Sanofi Names Belén Garijo as New CEO
13 Feb 2026 //
PRESS RELEASE
Sanofi Discloses Voting Rights And Shares For January 2026
11 Feb 2026 //
GLOBENEWSWIRE
Sanofi completes the acquisition of Dynavax
10 Feb 2026 //
PRESS RELEASE
Sanofi`s Rilzabrutinib Designated Breakthrough Therapy In US
09 Feb 2026 //
GLOBENEWSWIRE
Roche Unveils Data Behind BTK Inhibitor`s Phase 3 MS Win
09 Feb 2026 //
FIERCE BIOTECH
Fierce Biotech Fundraising Tracker `26: Angitia & More
09 Feb 2026 //
FIERCE BIOTECH
